Cognitive dysfunction and emotional-behavioural changes in MS: The potential of positron emission tomography

Journal of the Neurological Sciences

Volumn 245, Issue 1-2, 2006, Pages 9-13

  Herholz, Karl ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cerebral glucose metabolism; Cognitive dysfunction; Microglia; Molecular imaging; Multiple sclerosis; Positron emission tomography

Indexed keywords

DNA; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RNA;

ARTICLE; BEHAVIOR; COGNITIVE DEFECT; DEMYELINATION; DISEASE COURSE; EMOTION; FATIGUE; GLUCOSE METABOLISM; HUMAN; MICROGLIA; MOLECULAR IMAGING; MULTIPLE SCLEROSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENILE PLAQUE; WHITE MATTER;

BEHAVIORAL SYMPTOMS; COGNITION DISORDERS; EMOTIONS; ENERGY METABOLISM; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; POSITRON-EMISSION TOMOGRAPHY;

EID: 33646837376     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.09.012     Document Type: Article

References (47)

1. Herholz K., Herscovitch P., and Heiss W.D. NeuroPET (2004), Springer, Berlin/Heidelberg
2. Hasselbalch S.G., Knudsen G.M., Capaldo B., Postiglione A., and Paulson O.B. Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J Clin Endocrinol Metab 86 (2001) 1986-1990
3. Magistretti P.J., and Pellerin L. The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies. Mol Psychiatry 1 (1996) 445-452
4. Chih C.P., and Roberts Jr. E.L. Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J Cereb Blood Flow Metab 23 (2003) 1263-1281
5. Sokoloff L. Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. J Cereb Blood Flow Metab 1 (1981) 7-36 [Review]
6. Zhuang H., and Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32 (2002) 47-59
7. Reivich M., Kuhl D., Wolf A., Greenberg J., Phelps M., Ido T., et al. The [18F]fluorodeoxyglucose method for the measurement of local ce11rebral glucose utilization in man. Circ Res 44 (1979) 127-137
8. Hasselbalch S.G., Madsen P.L., Knudsen G.M., Holm S., and Paulson O.B. Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans. J Cereb Blood Flow Metab 18 (1998) 154-160
9. Sultzer D.L., Mahler M.E., Cummings J.L., Van Gorp W.G., Hinkin C.H., and Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Arch Neurol 52 (1995) 773-780
10. Pozzilli C., Fieschi C., Perani D., Paulesu E., Comi G., Bastianello S., et al. Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis. J Neurol Sci 112 (1992) 51-57
11. Bakshi R., Miletich R.S., Kinkel P.R., Emmet M.L., and Kinkel W.R. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 8 (1998) 228-234
12. Roelcke U., Kappos L., Lechnerscott J., Brunnschweiler H., Huber S., Ammann W., et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue-a F-18-fluorodeoxyglucose positron emission tomography study. Neurology 48 (1997) 1566-1571
13. Paulesu E., Perani D., Fazio F., Comi G., Pozzilli C., Martinelli V., et al. Functional basis of memory impairment in multiple sclerosis-a [F-18]FDG PET study. NeuroImage 4 (1996) 87-96
14. Blinkenberg M., Jensen C.V., Holm S., Paulson O.B., and Sorensen P.S. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology 53 (1999) 149-153
15. Blinkenberg M., Rune K., Jensen C.V., Ravnborg M., Kyllingsbaek S., Holm S., et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 54 (2000) 558-564
16. Brooks D.J., Leenders K.L., Head G., Marshall J., Legg N.J., and Jones T. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry 47 (1984) 1182-1191
17. Sun X., Tanaka M., Kondo S., Okamoto K., and Hirai S. Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med 12 (1998) 89-94
18. Newberg A., Hassan A., and Alavi A. Cerebral metabolic changes associated with Lyme disease. Nucl Med Commun 23 (2002) 773-777
19. Lang A.E., and Garnett E.S. Positron emission tomography in cases of chorea with different underlying disease. J Neurol Neurosurg Psychiatry 51 (1988) 1010-1011
20. Volkow N.D., Warner N., McIntyre R., Valentine A., Kulkarni M., Mullani N., et al. Cerebral involvement in systemic lupus erythematosus. Am J Physiol Imaging 3 (1988) 91-98
21. Stoppe G., Wildhagen K., Seidel J.W., Meyer G.J., Schober O., Heintz P., et al. Positron emission tomography in neuropsychiatric lupus erythematosus [see comments]. Neurology 40 (1990) 304-308
22. Kao C.H., Ho Y.J., Lan J.L., Changlai S.P., Liao K.K., and Chieng P.U. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 42 (1999) 61-68
23. Weiner S.M., Otte A., Schumacher M., Klein R., Gutfleisch J., Brink I., et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59 (2000) 377-385
24. Pozzilli C., Bernardi S., Mansi L., Picozzi P., Iannotti F., Alfano B., et al. Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J Neurol Neurosurg Psychiatry 51 (1988) 1058-1062
25. Jansen H.M., Willemsen A.T., Sinnige L.G., Paans A.M., Hew J.M., Franssen E.J., et al. Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis. J Neurol Sci 132 (1995) 139-145
26. Banati R.B. Visualising microglial activation in vivo. GLIA 40 (2002) 206-217
27. Vowinckel E., Reutens D., Becher B., Verge G., Evans A., Owens T., et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 50 (1997) 345-353
28. Banati R.B., Newcombe J., Gunn R.N., Cagnin A., Turkheimer F., Heppner F., et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 Pt. 11 (2000) 2321-2337
29. Debruyne J.C., Versijpt J., Van Laere K.J., De Vos F., Keppens J., Strijckmans K., et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol 10 (2003) 257-264
30. Versijpt J., Debruyne J.C., Van Laere K.J., De Vos F., Keppens J., Strijckmans K., et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler 11 (2005) 127-134
31. Pardridge W.M. Drug delivery to the brain. J Cereb Blood Flow Metab 17 (1997) 713-731
32. Li J.Y., Boado R.J., and Pardridge W.M. Blood-brain barrier genomics. J Cereb Blood Flow Metab 21 (2001) 61-68
33. Jacobs A., Voges J., Reszka R., Lercher M., Gossmann A., Kracht L., et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358 (2001) 727-729
34. Tjuvajev J.G., Finn R., Watanabe K., Joshi R., Oku T., Kennedy J., et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 56 (1996) 4087-4095
35. Tjuvajev J.G., Joshi A., Callegari J., Lindsley L., Joshi R., Balatoni J., et al. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1 (1999) 315-320
36. Liang Q., Gotts J., Satyamurthy N., Barrio J., Phelps M.E., Gambhir S.S., et al. Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. Mol Ther 6 (2002) 73-82
37. Wen B., Burgman P., Zanzonico P., O'donoghue J., Cai S., Finn R., et al. A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia. Eur J Nucl Med Mol Imaging 31 (2004) 1530-1538
38. 124I]FIAU in cat and man. J Nucl Med 42 (2001) 467-475
39. Alauddin M.M., and Conti P.S. Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 25 (1998) 175-180
40. Alauddin M.M., Shahinian A., Gordon E.M., Bading J.R., and Conti P.S. Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. J Nucl Med 42 (2001) 1682-1690
41. Yaghoubi S., Barrio J.R., Dahlbom M., Iyer M., Namavari M., Satyamurthy N., et al. Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med 42 (2001) 1225-1234
42. Min J.J., Iyer M., and Gambhir S.S. Comparison of [(18)F]FHBG and [(14)C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs. stable transfection. Eur J Nucl Med Mol Imaging 30 (2003) 1547-1560
43. Tavitian B., Terrazzino S., Kuhnast B., Marzabal S., Stettler O., Dolle F., et al. In vivo imaging of oligonucleotides with positron emission tomography. Nat Med 4 (1998) 467-471
44. Tavitian B., Marzabal S., Boutet V., Kuhnast B., Terrazzino S., Moynier M., et al. Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging. Pharm Res 19 (2002) 367-376
45. Adonai N., Nguyen K.N., Walsh J., Iyer M., Toyokuni T., Phelps M.E., et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A 99 (2002) 3030-3035
46. Koehne G., Doubrovin M., Doubrovina E., Zanzonico P., Gallardo H.F., Ivanova A., et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol (2003)
47. Olasz E.B., Lang L., Seidel J., Green M.V., Eckelman W.C., and Katz S.I. Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods 260 (2002) 137-148